Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | ||
|---|---|---|---|---|---|
| 1 | 2 | 3 | |||
| Anaphylactic shock | x | x | |||
| Angioedema | x | x | x | ||
| Asthenia | x | x | x | ||
| Cyanosis | x | x | x | ||
| Haemorrhage | x | x | x | ||
| Hypersensitivity | x | x | |||
| Nausea | x | ||||
| Pruritus | x | x | x | ||
| Pulmonary oedema | x | x | x | ||
| Sweating | x | x | x | ||
| Urticaria | x | x | x | ||
| Agitation | x | x | x | ||
| Tenderness | x | x | |||
| Throat tightness | x | x | x | ||
| Induration | x | x | |||
| Collapse | x | ||||
| Sensation of warmth | x | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |